| Product NDC: | 64980-130 |
| Proprietary Name: | LEVOCARNITINE |
| Non Proprietary Name: | LEVOCARNITINE |
| Active Ingredient(s): | 330 mg/1 & nbsp; LEVOCARNITINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 64980-130 |
| Labeler Name: | Rising Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076858 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040920 |
| Package NDC: | 64980-130-09 |
| Package Description: | 9 BLISTER PACK in 1 BOX (64980-130-09) > 10 TABLET in 1 BLISTER PACK |
| NDC Code | 64980-130-09 |
| Proprietary Name | LEVOCARNITINE |
| Package Description | 9 BLISTER PACK in 1 BOX (64980-130-09) > 10 TABLET in 1 BLISTER PACK |
| Product NDC | 64980-130 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LEVOCARNITINE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20040920 |
| Marketing Category Name | ANDA |
| Labeler Name | Rising Pharmaceuticals, Inc. |
| Substance Name | LEVOCARNITINE |
| Strength Number | 330 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Carnitine [Chemical/Ingredient],Carnitine Analog [EPC] |